What the team is known for
All-encompassing patent, trade mark and designs offering with expertise in biotechnology, chemicals, computer science, engineering and pharmaceuticals. Also has a powerful in-house patent litigation capability.
"They have an exceptional reputation in European patent work."
"They are very responsive and their actions are comprehensive and very considered."
Work highlights
Successfully defended Novartis in a European Patent Office (EPO) opposition hearing related to Zometa, an osteoporosis treatment.
Assisted clean technology enterprise Xeros with its European and US patent prosecution strategies.
Significant clients
Johnson & Johnson, Ionis Pharmaceuticals, DuPont Teijin Films, Micron Technology, Mars.
Individuals recognised by Chambers & Partners include:
Hugh Goodfellow advises biotechnology clients for pan-European patent prosecution matters. He also offers guidance on obtaining supplementary protection certificates.
Ian Kirby of Carpmaels & Ransford LLP leads the firm’s litigation practice and concentrates mostly on patent litigation for life sciences and technology companies. He also handles copyright and trade mark cases.
Cameron Marshall has a strong reputation for his excellent work ethic and impresses with his abilities in EPO opposition proceedings. He is particularly known for his representation of life sciences companies.
David Wilson of Carpmaels & Ransford LLP is a patent litigator with recent experience in chemicals, life sciences and technology cases. Clients say: “He has impressive technical knowledge and combines it with an excellent understanding of his client’s commercial objectives.”
